We validated in the clinical setting a putative clinical marker for a biological diagnosis of primary progressive aphasia (PPA) due to amyloid previously identified in an autopsy cohort and including impaired (score & LE;4) digit span (DS) as index of phonological loop dysfunction and broadened criteria for logopenic PPA. In 29 PPA patients with an amyloid-positive (A+) biomarker and 28 PPA patients with an amyloidnegative (A-) biomarker, Receiver Operating Characteristics (ROC) curve analysis showed moderate specificity (71%) but insufficient sensitivity (41%) for the proposed marker. Specificity was particularly poor (58%) for the discrimination between A+ PPA and the A- subgroup with nonfluent PPA. DS may be compromised in both logopenic and nonfluent PPA, whose loci of neurodegeneration lie at the 2 ends of the left fronto-parieto-temporal system that underpins phonology. An Statistical Parametric Mapping (SPM) correlation analysis between DS score and metabolism on brain 18-fluoro-deoxy-glucose positron emission tomography also showed a major contribution of the left frontal cortex to impaired span.& COPY; 2023 Elsevier Inc. All rights reserved.

Isella, V., Licciardo, D., Rebecchi, G., Ferri, F., Crivellaro, C., Appollonio, I., et al. (2023). A cognitive marker for Alzheimer disease pathology in primary progressive aphasia? A validation study in the clinical setting. NEUROBIOLOGY OF AGING, 131(November 2023), 153-155 [10.1016/j.neurobiolaging.2023.07.003].

A cognitive marker for Alzheimer disease pathology in primary progressive aphasia? A validation study in the clinical setting

Isella V.
Primo
;
Licciardo D.
Secondo
;
Ferri F.;Crivellaro C.;Appollonio I.
Penultimo
;
Ferrarese C.
Ultimo
2023

Abstract

We validated in the clinical setting a putative clinical marker for a biological diagnosis of primary progressive aphasia (PPA) due to amyloid previously identified in an autopsy cohort and including impaired (score & LE;4) digit span (DS) as index of phonological loop dysfunction and broadened criteria for logopenic PPA. In 29 PPA patients with an amyloid-positive (A+) biomarker and 28 PPA patients with an amyloidnegative (A-) biomarker, Receiver Operating Characteristics (ROC) curve analysis showed moderate specificity (71%) but insufficient sensitivity (41%) for the proposed marker. Specificity was particularly poor (58%) for the discrimination between A+ PPA and the A- subgroup with nonfluent PPA. DS may be compromised in both logopenic and nonfluent PPA, whose loci of neurodegeneration lie at the 2 ends of the left fronto-parieto-temporal system that underpins phonology. An Statistical Parametric Mapping (SPM) correlation analysis between DS score and metabolism on brain 18-fluoro-deoxy-glucose positron emission tomography also showed a major contribution of the left frontal cortex to impaired span.& COPY; 2023 Elsevier Inc. All rights reserved.
Articolo in rivista - Articolo scientifico
Alzheimer; Amyloid; Biomarker; Digit span; Logopenic; Primary progressive aphasia;
English
16-lug-2023
2023
131
November 2023
153
155
none
Isella, V., Licciardo, D., Rebecchi, G., Ferri, F., Crivellaro, C., Appollonio, I., et al. (2023). A cognitive marker for Alzheimer disease pathology in primary progressive aphasia? A validation study in the clinical setting. NEUROBIOLOGY OF AGING, 131(November 2023), 153-155 [10.1016/j.neurobiolaging.2023.07.003].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/449681
Citazioni
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
Social impact